About: Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial
Creator	Fang, Lei Cheng, Wei Fang, Min Mingfang, Xiao Zhan, Chao Zhang, Shuaipan Zhu, Qingguang
Source	Medline; PMC
abstract	BACKGROUND: In December 2019, pneumonia associated with the 2019 novel coronavirus (COVID-19) emerged in Wuhan, China. The number of cases has increased rapidly. Patients with severe disease have a poor prognosis, and there are no effective therapies for COVID-19. Only rapid advice guidelines for symptomatic supportive care have been used. A traditional Chinese medicine rehabilitation (TCMR) program consisting of acupressure therapy and Liu Zi Jue Qigong can be used as a complementary therapy for COVID-19. Hence, we designed a randomized trial to evaluate the efficacy and advantages of TCMR for treating patients with severe COVID-19. METHODS/DESIGN: This is a parallel-design, two-arm, analyst assessor-blinded, randomized controlled trial. A total of 128 patients with COVID-19 aged from 20 to 80 years will be recruited and assigned randomly into a guideline therapy group and a guideline therapy plus TCMR group at a 1:1 ratio. Patients in both groups will receive guideline therapy. The patients in the intervention group will perform acupressure therapy and Liu Zi Jue Qigong exercises in addition to conventional treatments twice a day and will be persistent from admission to discharge. The primary outcome will be measured with the Modified Medical Research Council Dyspnea Scale, and the secondary outcomes will include the Activities of Daily Living Barthel Index Scale, Patient Health Questionnaire-9 Scale, and the Respiratory Symptoms Scale. The assessments of the clinical scales will be performed at three points (before treatment, the 7th day during hospitalization, and the discharge day). Adverse events will be noted and recorded for the safety evaluation. DISCUSSION: This trial will provide high-quality evidence of the value of TCMR, which consists of acupressure therapy and Liu Zi Jue Qigong exercises, for treating patients with severe COVID-19. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000029994. Registered on 18 February 2020
has issue date	2020-08-27(xsd:dateTime)
bibo:doi	10.1186/s13063-020-04693-5
bibo:pmid	32854761
has license	cc-by
sha1sum (hex)	2d29b8815d4b320b882d8b34c17c967ec1d3766d
schema:url	https://doi.org/10.1186/s13063-020-04693-5
resource representing a document's title	Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial
has PubMed Central identifier	PMC7450683
has PubMed identifier	32854761
schema:publication	Trials
resource representing a document's body	covid:2d29b8815d4b320b882d8b34c17c967ec1d3766d#body_text
is schema:about of	named entity 'life' named entity 'pneumonia' named entity 'patients' named entity 'Qigong' named entity 'acupressure' named entity 'RCT' named entity '18 February 2020' named entity 'supportive treatment' named entity 'acute respiratory distress syndrome' named entity 'quality of life' named entity 'Qigong' named entity 'relaxed state' named entity 'Liu Zi Jue' named entity 'quality of life' named entity 'fatigue' named entity 'principal investigator' named entity 'organ failure' named entity 'chest tightness' named entity 'quality of life' named entity 'pneumonitis' named entity 'Infectious Diseases' named entity 'control group' named entity 'Fisher's exact test' named entity 'Wuhan' named entity 'Clinical Trial' named entity 'cough' named entity 'COVID-19' named entity 'periarthritis' named entity 'Dyspnea' named entity 'standard deviation' named entity 'nasal congestion' named entity 'Department of Science and Technology' named entity 'shiatsu' named entity 'breathing difficulties' named entity 'data management' named entity 'blood coagulation' named entity 'Ethics' named entity 'lung disease' named entity 'dyspnea' named entity 'random number generator' named entity 'TCM' named entity 'physical health' named entity 'intention-to-treat analysis' named entity 'data quality' named entity 'gas exchange' named entity 'China' named entity 'antibiotics' named entity 'clinical experience' named entity 'acupressure' named entity 'microorganisms' named entity 'physiotherapists' named entity 'infection' named entity 'pulmonary function' named entity 'quality of life' named entity 'Liu Zi Jue' named entity 'muscle' named entity 'mental health' named entity 'randomized controlled trial' named entity 'Qigong' named entity 'nonspecific symptoms' named entity 'Huangshi' named entity 'standard deviation' named entity 'Liu Zi Jue' named entity 'Qigong' named entity 'trial protocol' named entity 'Traditional Chinese Medicine' named entity 'COVID-19' named entity 'Activities of Daily Living' named entity 'epidemiological' named entity 'COVID-19' named entity 'mental illness' named entity 'IBM' named entity 'Liu Zi Jue' named entity 'cough' named entity 'acupoint'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software